 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
   |
| MJNA CEO to Speak About CBD Oil Use in Autism Patients at Neuroscience Conference |
|
 Hot Stock to Watch |
Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)
|
Last:
Price: 0.07
Change (%): + 0.00 (0.00)
Volume: 862,819 |
 |
Medical Marijuana, Inc. Announces CEO Dr. Stuart Titus as Speaker at Autism Tree Project Foundation 3rd Annual Neuroscience Conference
SAN DIEGO, Oct. 25, 2017 /PRNewswire/ - Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that CEO Dr. Stuart Titus will be speaking on the CBD oil panel at the Autism Tree Project Foundation 3rd Annual Neuroscience Conference, being held at the Sanford Consortium from 10:45 a.m. to 12:00 p.m. on Thursday October 26, 2017.
Dr. Titus will be speaking on the panel with Dr. Keith Vaux and Audrey Kerger about the results of CBD oil use in autism patients how these results have the capacity to expand current research on autism, and how the future treatment of autism disorders could be. Other medical doctors, neuroscientists, and field experts will also be presenting on various panels and presentations throughout the day.
“We are extremely proud and thankful to be participating in such an important field of study,” said Dr. Titus. “We are confident that with our extensive background and knowledge in the field of cannabis and cannabidiol research that the audience will be informed with the most up-to-date and thorough information possible, in addition to the clinical data on both the botanical as well as pharmaceutical side. Those interested in exploring cannabidiol products will greatly benefit from this informative panel.”
Those interested in speaking with Dr. Stuart Titus about his research on the CBD oil use are encouraged to stop by the HempMeds table to speak with him or a company representative.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
